BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 261 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,059,653 | +256.0% | 9,964 | +70.2% | 0.00% | – |
| Q3 2023 | $297,660 | -26.4% | 5,856 | -5.6% | 0.00% | – |
| Q2 2023 | $404,246 | -41.3% | 6,202 | -59.6% | 0.00% | -100.0% |
| Q1 2023 | $688,536 | -31.2% | 15,340 | -34.3% | 0.00% | 0.0% |
| Q4 2022 | $1,001,400 | -21.9% | 23,359 | +22.4% | 0.00% | -50.0% |
| Q3 2022 | $1,283,000 | -35.5% | 19,090 | -50.5% | 0.00% | -33.3% |
| Q2 2022 | $1,990,000 | +20.2% | 38,553 | +50.1% | 0.00% | +50.0% |
| Q1 2022 | $1,656,000 | +333.5% | 25,681 | +593.9% | 0.00% | – |
| Q3 2021 | $382,000 | -29.8% | 3,701 | -40.1% | 0.00% | -100.0% |
| Q2 2021 | $544,000 | +28.9% | 6,179 | +41.3% | 0.00% | – |
| Q1 2021 | $422,000 | -50.6% | 4,372 | -42.6% | 0.00% | -100.0% |
| Q4 2020 | $854,000 | +258.8% | 7,620 | +202.3% | 0.00% | – |
| Q2 2019 | $238,000 | +7.2% | 2,521 | -9.2% | 0.00% | – |
| Q1 2019 | $222,000 | – | 2,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |